Michele Ollier

Michele Ollier has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Minerva Neurosciences, Inc. and Aegerion Pharmaceuticals, Inc. In total, 13 filings cover trades dated from 27 October 2010 to 12 December 2016.

Both buying and selling appear: 4 purchases worth €10.2M, against 3 sales worth €18.2M. Taken together, the sales exceed the purchases by €7.9M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 1 share grant. 2016 to date brings no purchases and 1 sale.

Half of the purchases are above €1.8M and half below.

The newest entry dates from 14 December 2016: a share grant of €1.1M, in Minerva Neurosciences, Inc. The latest purchase dates back some time: it was published 4,252 days ago, on 20 March 2015. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.